Pancreatic Cancer Research

ResearcherQiqihar Medical UniversityNo recent work listed

Ying Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9977-1600; OpenAlex author ID A5100414367. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. Coix seed oil regulates mitochondrial functional damage to induce apoptosis of human pancreatic cancer cells via the PTEN/PI3K/AKT signaling pathway. First author DOI 10.1007/s11033-022-07371-8↗
  2. Survival outcome after stereotactic body radiotherapy for locally advanced and borderline resectable pancreatic cancer: A systematic review and meta-analysis. First author DOI 10.1016/j.tranon.2021.101139↗
  3. (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN. Co-author DOI 10.3892/mmr.2016.5277↗
  4. Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts. Co-author DOI 10.1186/1472-6882-14-228↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian Yang · 2 shared papers, 2021–2022 · strength 0.31
  2. Shi Liu · 1 shared paper, 2022 · strength 0.17
  3. Changming Ma · 1 shared paper, 2021 · strength 0.14
  4. Min Li · 1 shared paper, 2021 · strength 0.14
  5. Shi Liu · 1 shared paper, 2021 · strength 0.14
  6. Shi Liu · 1 shared paper, 2014 · strength 0.06
  7. Shi Liu · 1 shared paper, 2016 · strength 0.06
  8. Wei Qin · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.